![Omer Siddiqui](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Omer Siddiqui worked as Vice President of Clinical Operations at Allakos, Inc. from 2016 to 2017.
He then worked as Vice President and Head of Development Operations at Alector, Inc. After that, he worked as VP of Development Operations and Project Management at Harpoon Therapeutics, Inc. from 2020 to 2022.
Siddiqui completed his undergraduate degree at the University of Western Ontario.
Precedenti posizioni note di Omer Siddiqui
Società | Posizione | Fine |
---|---|---|
HARPOON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2022 |
ALLAKOS INC. | Corporate Officer/Principal | 01/06/2017 |
ALECTOR, INC. | Corporate Officer/Principal | - |
Formazione di Omer Siddiqui
University of Western Ontario | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ALLAKOS INC. | Health Technology |
ALECTOR, INC. | Health Technology |
Aziende private | 1 |
---|---|
Harpoon Therapeutics, Inc.
![]() Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Omer Siddiqui